| Date Filed | Type | Description |
| 02/14/2022 |
SC 13G/A
| Consonance Capital Management LP reports a 0% stake in GENMARK DIAGNOSTICS INC |
| 05/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/03/2021 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 04/28/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 04/22/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/22/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/22/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/22/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/22/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/22/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/22/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/22/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/22/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/22/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/22/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/22/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/22/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/22/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/22/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/22/2021 |
4
| Giles Lisa M. (Director) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Unknown transaction of 81,572 shares
@ $24.05, valued at
$2M
Unknown transaction of 5,500 shares
@ $24.05, valued at
$132.3k
Disposed/sold 19,062 options to buy
@ $13.17, valued at
$251k
|
|
| 04/22/2021 |
4
| Kagnoff Michael (Director) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Unknown transaction of 137,319 shares
@ $24.05, valued at
$3.3M
Disposed/sold 19,062 options to buy
@ $13.17, valued at
$251k
|
|
| 04/22/2021 |
4
| Fox James (Director) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Unknown transaction of 182,017 shares
@ $24.05, valued at
$4.4M
Unknown transaction of 81,085 shares
@ $24.05, valued at
$2M
|
|
| 04/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
4
| Stevenson Wade R. (SVP, North America Sales) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Unknown transaction of 50,000 shares
@ $24.05, valued at
$1.2M
|
|
| 04/22/2021 |
4
| Shaw Christine (VP, Assay Development) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Unknown transaction of 101,324 shares
@ $24.05, valued at
$2.4M
Disposed/sold 17,500 options to buy
@ $0 |
|
| 04/22/2021 |
4
| Winkler Sarah Hollis (VP, Human Resources) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Unknown transaction of 147,502 shares
@ $24.05, valued at
$3.5M
Disposed/sold 6,668 options to buy
@ $0
Disposed/sold 33,334 options to buy
@ $0
Disposed/sold 12,500 options to buy
@ $0 |
|
| 04/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
4
| Jensen Tyler (SVP, Engineering and Tech Dev) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Unknown transaction of 212,249 shares
@ $24.05, valued at
$5.1M
Disposed/sold 11,668 options to buy
@ $0
Disposed/sold 40,000 options to buy
@ $0
Disposed/sold 12,500 options to buy
@ $0 |
|
| 04/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
4
| Chohan Abdul (SVP Operations) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Unknown transaction of 63,750 shares
@ $24.05, valued at
$1.5M
Disposed/sold 12,500 options to buy
@ $0 |
|
| 04/22/2021 |
4
| Stier Eric (SVP & General Counsel) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Unknown transaction of 275,974 shares
@ $24.05, valued at
$6.6M
Disposed/sold 15,832 options to buy
@ $0
Disposed/sold 35,000 options to buy
@ $0
Disposed/sold 12,500 options to buy
@ $0
Disposed/sold 30,000 options to buy
@ $8.5, valued at
$255k
Disposed/sold 62,000 options to buy
@ $12.3, valued at
$762.6k
Disposed/sold 55,550 options to buy
@ $13.17, valued at
$731.6k
|
|
| 04/22/2021 |
4
| Harkins Michael John (SVP, Sales) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Unknown transaction of 144,214 shares
@ $24.05, valued at
$3.5M
Disposed/sold 38,334 options to buy
@ $0
Disposed/sold 7,500 options to buy
@ $0 |
|
| 04/22/2021 |
4
| Gleeson Michael (SVP, Corp. Accounts) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Unknown transaction of 421,383 shares
@ $24.05, valued at
$10.1M
Unknown transaction of 30,069 shares
@ $24.05, valued at
$723.2k
Disposed/sold 20,213 options to buy
@ $10.89, valued at
$220.1k
Disposed/sold 62,046 options to buy
@ $12.3, valued at
$763.2k
Disposed/sold 55,674 options to buy
@ $13.17, valued at
$733.2k
Disposed/sold 16,668 options to buy
@ $0
Disposed/sold 38,334 options to buy
@ $0
Disposed/sold 12,500 options to buy
@ $0 |
|
|